Gelimer H. Genzel
Munich, BY 80937, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Deploy to Diagnose: Enhancing Pandemic Preparedness With NATO Field Lab Capabilities.
Journal: Military medicine
Published: January 29, 2025
Discrimination of Human Pathogen Clostridium Species Especially of the Heterogeneous C. sporogenes and C. botulinum by MALDI-TOF Mass Spectrometry.
Journal: Current microbiology
Published: April 09, 2018
Finafloxacin overcomes Burkholderia pseudomallei efflux-mediated fluoroquinolone resistance.
Journal: The Journal of antimicrobial chemotherapy
Published: January 01, 2017
MinION as part of a biomedical rapidly deployable laboratory.
Journal: Journal of biotechnology
Published: September 30, 2016
Mobile diagnostics in outbreak response, not only for Ebola: a blueprint for a modular and robust field laboratory.
Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
Published: May 31, 2015
Activity of the investigational fluoroquinolone finafloxacin and seven other antimicrobial agents against 114 obligately anaerobic bacteria.
Journal: International journal of antimicrobial agents
Published: December 05, 2013
Discrimination of Enterobacteriaceae and Non-fermenting Gram Negative Bacilli by MALDI-TOF Mass Spectrometry.
Journal: The open microbiology journal
Published: February 18, 2013
In vitro activities of levofloxacin, gatifloxacin, moxifloxacin and garenoxacin against Bacteroides fragilis strains evaluated by kill kinetics.
Journal: Journal of medical microbiology
Published: January 16, 2013
A step towards the discrimination of beta-lactamase-producing clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosa by MALDI-TOF mass spectrometry.
Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: September 01, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026